Results 111 to 120 of about 78,155 (256)
ABSTRACT Duodenal varices, though rare, are potentially life‐threatening complications of portal hypertension. Management is challenging when balloon‐occluded retrograde transvenous obliteration (BRTO) fails to achieve complete obliteration. Endoscopic ultrasonography‐guided variceal therapy (EUS‐VT) is effective for gastric varices, but reports of ...
Sakue Masuda +6 more
wiley +1 more source
PTU-015 Natural history of varices in the era of non-invasive assessment [PDF]
Michael Johnston, Mark Wright
openalex +1 more source
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
G. Garcia‐Tsao +3 more
semanticscholar +1 more source
Evaluation and Management of Esophageal and Gastric Varices in Patients with Cirrhosis.
S. Jakab, G. Garcia‐Tsao
semanticscholar +1 more source
Predictors of Delayed Recovery in Ambulatory Advanced Endoscopic Procedures
ABSTRACT Background There is a scarcity of data evaluating patient‐related outcomes of advanced or complex endoscopy (ACE) through the post‐anesthesia recovery course. Yet, gastrointestinal distress following ACE can occur commonly, and this may impact recovery length of stay and the approach to post‐anesthesia care.
Zoilo K. Suarez +8 more
wiley +1 more source
Effect of previous sclerotherapy on the outcome of gastro-oesophageal devascularization and oesophageal transection in bleeding oesophageal varices [PDF]
Mohammed K. Alam +3 more
openalex +1 more source
ABSTRACT Objective Gel‐immersion endoscopic injection sclerotherapy (GI‐EIS) addresses the technical challenges in intravariceal injection for esophageal varices (EVs). However, gel accumulation may obscure the variceal morphology. Thus, we developed GI‐EIS under texture and color enhancement imaging (TXI) and evaluated its effectiveness.
Tsunetaka Kato +15 more
wiley +1 more source
ABSTRACT Endoscopic submucosal dissection (ESD) is widely used for early esophageal cancer, even in patients with liver cirrhosis (LC). Corticosteroids, administered orally or by local injection, are often used to prevent post‐ESD esophageal stricture. However, their safety in patients with decompensated LC and refractory ascites remains unclear. A man
Yuki Tamura +9 more
wiley +1 more source
Introduction Bevacizumab, a vascular endothelial growth factor inhibitor, is used off‐label for treatment of severe anaemia related to epistaxis, gastrointestinal bleeding and/or severe hepatic arteriovenous malformations (HAVM) and right‐sided cardiac failure in patients with hereditary haemorrhagic telangiectasia (HHT).
Pernille D. Haahr +18 more
wiley +1 more source

